GlassScriptPhysician profile
Kenneth A Shaver
NPI 1629090949
$4,250.21
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,492 · 2020: $509 · 2021: $221 · 2022: $29.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $906.40 | 2019-2020 | |
| Novo Nordisk INC | $767.78 | 2019 | |
| Lilly USA, LLC | $401.25 | 2019 | |
| Allergan, INC. | $370.34 | 2019 | |
| Amarin Pharma, INC. | $360.85 | 2019-2020 | |
| Pfizer INC. | $275.61 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.91 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $251.18 | 2019-2020 | |
| Glaxosmithkline, LLC. | $196.72 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.08 | 2019-2020 | |
| Amgen INC. | $106.31 | 2019-2020 | |
| Redhill Biopharma INC. | $97.56 | 2021 | |
| Astellas Pharma US INC | $37.54 | 2019 | |
| Shire North American Group INC | $37.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.79 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.66 | 2020 | |
| Upsher-Smith Laboratories LLC | $15.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.73 | 2019 | |
| Medtronic, INC. | $14.38 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Shaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.